Subfertility Clinical Trial
Official title:
A Randomized Controlled Trial of Clinical Effectiveness of Freezing All Embryos Followed by Frozen Thawed Embryo Transfer Compared to Fresh Embryo Transfer, in Women Undergoing In-vitro Fertilization Treatment
The objective of the present randomized controlled study is to compare clinical effectiveness and safety of freezing all embryos followed by frozen-thawed embryo transfer (FET) compared to fresh embryo transfer, in women undergoing IVF treatment.
A total of 800 infertile women undergoing IVF treatment will be randomized into one of the
following two groups by computer-generated random numbers:
Fresh embryo transfer group: a single fresh embryo transfer FET group: a single FET following
freezing of all embryos in the stimulated IVF cycle
All techniques of IVF including ovarian stimulation, harvesting of oocytes, insemination with
specially prepared sperm and embryo culture in the laboratory will be according to local
protocols. Once the embryos have been cultured up to day 2 or 3, women with 3 or more
suitable quality embryos will be randomized to either fresh embryo transfer (control arm) or
FET (Intervention arm).
Control arm Women allocated to the control arm will either undergo embryo transfer at
cleavage stage or extended culture and transfer at blastocyst stage according to local
policy. A maximum of 2 embryos or blastocysts will be replaced according to the standard
protocol under transabdominal ultrasound guidance. Luteal phase support is given according to
local protocols.
Intervention arm For those allocated to the intervention arm fresh embryo transfer will not
be undertaken. Embryos will be frozen by vitrification or slow freezing at cleavage or
blastocyst stage according to standard agreed local protocols. Women will be contacted after
4 weeks and arrangements made for frozen embryo transfer.
After at least 4 weeks women will attend the IVF clinic for the transfer of thawed frozen
embryos, either in a natural cycle (in ovulatory women who have regular menstrual cycles) or
in a hormonally supported cycle using physiological doses of estrogen and progestogens to
mimic normal cyclical changes within the endometrium. The choice between replacing
frozen-thawed embryos in a natural or hormonally mediated cycle will be a decision driven by
the clinical circumstances.
Embryos or blastocysts will be thawed according to local protocols. The transfer is performed
by the team clinician with a maximum of 2 embryos or blastocysts being replaced according to
the standard protocol under transabdominal ultrasound guidance. Luteal phase support is given
at the discretion of the physician.
Follow up strategy:
A pregnancy test will be carried out 2 weeks after embryo transfer in both arms. All women
who have a positive pregnancy test 2 weeks after embryo transfer will undergo a transvaginal
ultrasound scan to identify the presence and number of a gestation sac with a fetal heart
signifying an ongoing pregnancy. Pelvic scan will be repeated at 8 weeks, 12 weeks, 24 weeks
and 36 gestation for fetal growth.
Data on all pregnancy outcomes including early pregnancy losses such as miscarriage or
ectopic pregnancy will be collected.
In order to achieve consistency with respect to the collection of outcome, standardised case
report forms (CRF) will be completed for each woman at each centre. These CRFs will include
details on treatment received, pregnancy outcomes, complications in pregnancy, mode of
delivery and birth outcomes.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03569787 -
Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire
|
||
Completed |
NCT03105453 -
The Microbiome in Subfertility and Assisted Reproductive Technologies (ART)
|
||
Terminated |
NCT02180256 -
Effect of Endometrial Scratching on Assisted Reproduction Outcomes: a Randomized Controlled Trial
|
N/A | |
Terminated |
NCT02197832 -
A RCT on the Effect of Endometrial Injury on Improving Ongoing Pregnancy Rate in Subfertile Women Undergoing FET Cycles
|
N/A | |
Completed |
NCT00971152 -
Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle
|
Phase 3 | |
Completed |
NCT01569945 -
Hormonal Stimulation in IUI Treatment: Is Clomifen Combined With Ethinyl Estradiol Better, Worse or Equal to Menopur
|
N/A | |
Recruiting |
NCT04064840 -
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
|
Phase 3 | |
Recruiting |
NCT02561793 -
DHEA Versus Placebo in Women With Poor Ovarian Response
|
Phase 3 | |
Completed |
NCT02197208 -
A RCT Comparing Spontaneous Natural Cycles and Human Chorionic Gonadotrophin-induced Natural Cycles in FET
|
N/A | |
Completed |
NCT01961336 -
Transdermal Testosterone Pretreatment in Poor Responders Undergoing IVF
|
Phase 3 | |
Completed |
NCT02487940 -
Assessment of Intralipid Efficacy in Women With Unexplained Recurrent Implantation Failure
|
Phase 4 | |
Completed |
NCT01385618 -
Gene-polymorphisms Relating to Human Subfertility
|
N/A | |
Completed |
NCT00985062 -
Mild Versus Conventional Ovarian Stimulation Treatment for In Vitro Fertilization
|
N/A | |
Recruiting |
NCT04538560 -
Preimplantation Genetic Testing for Aneuploidy of Polar Bodies
|
N/A | |
Completed |
NCT02748278 -
Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment
|
||
Completed |
NCT02044445 -
Is the IVF Outcome Dependent on the Time Interval Between hCG Administration and Oocyte Retrieval?
|
N/A | |
Completed |
NCT02863614 -
Analgesia for Endometrial Scratching
|
N/A | |
Completed |
NCT02151006 -
Does Dehydro Epiandrosterone (DHEA) Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response?
|
Phase 3 | |
Completed |
NCT02154958 -
Role of Follicular Output Rate in the Prediction of in Vitro Fertilization and Intracytoplasmic Sperm Injection in Women With Unexplained Infertility
|
N/A | |
Completed |
NCT01067664 -
Prognostic Value of Progesterone for In Vitro Fertilization (IVF) Outcome
|
N/A |